GDAR logo

Golden Age Resources OTCPK:GDAR Stock Report

Last Price

US$0.000001

Market Cap

US$3.4k

7D

0%

1Y

n/a

Updated

26 Mar, 2024

Data

Company Financials

Golden Age Resources, Inc.

OTCPK:GDAR Stock Report

Market Cap: US$3.4k

GDAR Stock Overview

Golden Age Resources Inc., an acquisition and development company, focus on the development of prescription and over the counter medicines in the United States.

GDAR fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Golden Age Resources, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Golden Age Resources
Historical stock prices
Current Share PriceUS$0.000001
52 Week HighUS$0.000001
52 Week LowUS$0.000001
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change-99.50%
5 Year Change-99.00%
Change since IPO-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

GDARUS PharmaceuticalsUS Market
7D0%-0.2%0.6%
1Yn/a23.9%29.5%

Return vs Industry: Insufficient data to determine how GDAR performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how GDAR performed against the US Market.

Price Volatility

Is GDAR's price volatile compared to industry and market?
GDAR volatility
GDAR Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.5%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: GDAR has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine GDAR's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2008n/aDaniel Koganhttps://www.gdarinc.com

Golden Age Resources Inc., an acquisition and development company, focus on the development of prescription and over the counter medicines in the United States. The company offers its products in the areas of cardiovascular, anti-microbial, immunity, arthritis, pain relief, and other therapeutic areas. Its product portfolio include Nitrosorbid, a vasodilator for the treatment of angina pectoris; Ampicillin Trihydrate, an antibiotic-penicillin; Analgin, a pain relief; Corvalol to treat neuroses with heightened irritability/insomnia/hypertension/non-acute spasm of coronary vessels/tachycardia/gastrointestinal cramping; Tubosan, an immune stimulator; and Lovastatin for the treatment of dyslipidemia, as well as for the prevention of cardiovascular diseases.

Golden Age Resources, Inc. Fundamentals Summary

How do Golden Age Resources's earnings and revenue compare to its market cap?
GDAR fundamental statistics
Market capUS$3.38k
Earnings (TTM)US$0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GDAR income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$0
EarningsUS$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did GDAR perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.